These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27571186)

  • 21. Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study.
    Wang Y; Zhou W; Wu C; Zhang Y; Lin T; Sun Y; Liu W; Tao T
    Reprod Biol Endocrinol; 2018 Mar; 16(1):31. PubMed ID: 29587769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
    Pelusi C; Fanelli F; Pariali M; Zanotti L; Gambineri A; Pasquali R
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1575-82. PubMed ID: 23928669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance.
    Cupisti S; Häberle L; Dittrich R; Oppelt PG; Reissmann C; Kronawitter D; Beckmann MW; Mueller A
    Fertil Steril; 2010 Jul; 94(2):673-7. PubMed ID: 19394003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of increased lean muscle mass in women with polycystic ovary syndrome.
    Carmina E; Guastella E; Longo RA; Rini GB; Lobo RA
    Eur J Endocrinol; 2009 Oct; 161(4):583-9. PubMed ID: 19605540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome.
    Tripathy P; Sahu A; Sahu M; Nagy A
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():18-22. PubMed ID: 28850821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome.
    Dumesic DA; Turcu AF; Liu H; Grogan TR; Abbott DH; Lu G; Dharanipragada D; Chazenbalk GD
    J Endocr Soc; 2023 Jul; 7(8):bvad079. PubMed ID: 37404244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
    Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
    Tosi F; Dorizzi R; Castello R; Maffeis C; Spiazzi G; Zoppini G; Muggeo M; Moghetti P
    Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome.
    Barber TM; Golding SJ; Alvey C; Wass JA; Karpe F; Franks S; McCarthy MI
    J Clin Endocrinol Metab; 2008 Mar; 93(3):999-1004. PubMed ID: 18089693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.
    Carmina E; Orio F; Palomba S; Longo RA; Lombardi G; Lobo RA
    Fertil Steril; 2005 Aug; 84(2):413-9. PubMed ID: 16084883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming.
    Leung KL; Sanchita S; Pham CT; Davis BA; Okhovat M; Ding X; Dumesic P; Grogan TR; Williams KJ; Morselli M; Ma F; Carbone L; Li X; Pellegrini M; Dumesic DA; Chazenbalk GD
    Clin Epigenetics; 2020 Nov; 12(1):181. PubMed ID: 33228780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body composition, glucose metabolism markers and serum androgens - association in women with polycystic ovary syndrome.
    Kozakowski J; Zgliczyński W
    Endokrynol Pol; 2013; 64(2):94-100. PubMed ID: 23653271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
    Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
    J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study.
    Tagliaferri V; Romualdi D; Scarinci E; Cicco S; Florio CD; Immediata V; Tropea A; Santarsiero CM; Lanzone A; Apa R
    Reprod Sci; 2018 Feb; 25(2):269-275. PubMed ID: 28558523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
    Bizzarri C; Benevento D; Ravà L; Patera IP; Schiaffini R; Ciampalini P; Giannone G; Cappa M
    Fertil Steril; 2011 Dec; 96(6):1497-1502.e1. PubMed ID: 21982726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.
    González F; Considine RV; Abdelhadi OA; Acton AJ
    J Clin Endocrinol Metab; 2020 Jun; 105(6):e2152-67. PubMed ID: 32140727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.